Expres2ion Biotech Hldg Stock Debt To Equity
| 5JD Stock | EUR 1.77 0.06 3.28% |
EXPRES2ION BIOTECH HLDG fundamentals help investors to digest information that contributes to EXPRES2ION BIOTECH's financial success or failures. It also enables traders to predict the movement of EXPRES2ION Stock. The fundamental analysis module provides a way to measure EXPRES2ION BIOTECH's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to EXPRES2ION BIOTECH stock.
EXPRES2ION |
EXPRES2ION BIOTECH HLDG Company Debt To Equity Analysis
EXPRES2ION BIOTECH's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current EXPRES2ION BIOTECH Debt To Equity | 0.02 % |
Most of EXPRES2ION BIOTECH's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, EXPRES2ION BIOTECH HLDG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
According to the company disclosure, EXPRES2ION BIOTECH HLDG has a Debt To Equity of 0.022%. This is 99.96% lower than that of the Healthcare sector and 99.89% lower than that of the Biotechnology industry. The debt to equity for all Germany stocks is 99.95% higher than that of the company.
EXPRES2ION Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EXPRES2ION BIOTECH's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of EXPRES2ION BIOTECH could also be used in its relative valuation, which is a method of valuing EXPRES2ION BIOTECH by comparing valuation metrics of similar companies.EXPRES2ION BIOTECH is currently under evaluation in debt to equity category among its peers.
EXPRES2ION Fundamentals
| Return On Equity | -0.57 | |||
| Return On Asset | -0.34 | |||
| Shares Outstanding | 37.15 M | |||
| Shares Owned By Institutions | 1.71 % | |||
| Gross Profit | 6.22 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 12.79 X | |||
| Number Of Employees | 27 | |||
| Beta | 1.46 | |||
| Market Capitalization | 44 M |
About EXPRES2ION BIOTECH Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze EXPRES2ION BIOTECH HLDG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EXPRES2ION BIOTECH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EXPRES2ION BIOTECH HLDG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in EXPRES2ION Stock
EXPRES2ION BIOTECH financial ratios help investors to determine whether EXPRES2ION Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EXPRES2ION with respect to the benefits of owning EXPRES2ION BIOTECH security.